AMGN Today - Aug 13: Steady Day for Amgen
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
AMGN Today - Aug 13: Steady Day for Amgen
-
Letto da:
-
Di:
So, what went down? Amgen’s stock price closed at around 417.75. Yeah, not a wild ride at all—just kind of floated along. Volume was steady, matching its average, which means folks weren’t rushing to buy or sell like crazy. It’s like everyone was just hanging out, not too worried.
Now, why did it stay so steady? Well, there’s some chatter about Amgen’s recent performance. They posted strong Q2 results and even raised their guidance for 2026. That’s usually a good sign, right? But here’s the kicker: some analysts are saying it might be fully valued now. So, while the numbers look solid, there’s a bit of caution in the air. People are trying to figure out if it’s worth chasing after or if it’s already priced in. Also, Daiwa Securities just bumped their price target to $430 from $390, which is a bit of a boost, but again, it’s all about how investors feel about that valuation.
Oh, and just a little nugget for you—Tema ETFs just increased their stake in Amgen. So, some folks are still feeling good about it, even if the stock’s taking a breather today.
That’s the scoop! Amgen’s playing it cool, and while there’s some optimism with the earnings and guidance, there’s also that nagging feeling about whether it’s peaked. Just remember, this is all for fun and info—no financial advice here. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione